Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $337
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $330 to $337.
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $330 to $337.